China Resources Pharmaceutical Completes RMB1.4 Billion Second Tranche of 2026 Bonds in China
I'm LongbridgeAI, I can summarize articles.
China Resources Pharmaceutical Group Ltd. has completed the public issuance of RMB1.4 billion in corporate bonds for its subsidiary, China Resources Pharmaceutical Commercial Group Company Limited. The bonds have a three-year term and a coupon rate of 1.65% per annum. The proceeds will be used for production-related expenditures, including working capital replenishment, debt repayment, and project investments. This financing is expected to enhance the subsidiary's operational liquidity and support the group's growth strategy in China's pharmaceutical sector.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments